Compare $EDIT vs $EIKN | Chartloom

Compare

$EDIT vs $EIKN

Editas Medicine Inc · Eikon Therapeutics Inc

EDIT

Editas Medicine Inc

EIKN

Eikon Therapeutics Inc

Compare $EDIT vs $EIKN

Comparing Editas Medicine Inc and Eikon Therapeutics Inc

EDITEditas Medicine Inc

EIKNEikon Therapeutics Inc

EDITEditas Medicine Inc

Market cap

$487M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

27.22x

Rev growth (TTM)

20.8%

YTD performance

41.5%

52W performance

-30.1%

FCF yield

-24.8%

EIKNEikon Therapeutics Inc

Market cap

$404M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-50.2%

52W performance

-50.2%

FCF yield

-96.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

EDIT

EIKN

Detailed metrics comparison

EDIT

Editas Medicine Inc

EIKN

Eikon Therapeutics Inc

Market Cap

EDIT$487M

EIKN$404M

Enterprise Value

EDIT$361M

EIKN$262M

Price

EDIT$2.90

EIKN$7.47

P/E Ratio

EDITN/A

EIKNN/A

P/S Ratio

EDIT10.35x

EIKN0.00x

EV/Sales

EDIT7.67x

EIKN0.00x

EV/EBITDA

EDIT0.00x

EIKN0.00x

P/B Ratio

EDIT3.82x

EIKN0.85x

P/FCF Ratio

EDITN/A

EIKNN/A

EV/FCF

EDIT-2.99x

EIKN-0.67x

PEG Ratio

EDITN/A

EIKN0.00x

Forward P/E (NTM)

EDITN/A

EIKNN/A

Forward P/S (NTM)

EDIT27.22x

EIKNN/A

Revenue (TTM)

EDIT$47M

EIKN$0

Revenue Growth (YoY)

EDIT20.8%

EIKNN/A

Forward Rev Growth

EDIT-18.4%

EIKN436.8%

Gross Margin (TTM)

EDIT0.0%

EIKN0.0%

Operating Margin (TTM)

EDIT0.0%

EIKN0.0%

EBITDA Margin (TTM)

EDIT-172.4%

EIKN0.0%

Net Margin (TTM)

EDIT-157.3%

EIKN0.0%

FCF Margin (TTM)

EDIT-256.5%

EIKNN/A

Net Income (TTM)

EDIT$-74M

EIKN$-505M

FCF (TTM)

EDIT$-121M

EIKN$-391M

EPS (TTM)

EDIT-$0.62

EIKN-$9.33

ROE (TTM)

EDIT-19663.0%

EIKN-11966.0%

ROA (TTM)

EDIT-3817.0%

EIKN-6914.0%

ROIC (TTM)

EDIT-7815.0%

EIKN-11966.0%

Cash

EDIT$182M

EIKN$143M

Debt

EDIT$56M

EIKN$0

Net Cash/Debt

EDIT$126M

EIKN$143M

Current Ratio (TTM)

EDIT3.19x

EIKN9.89x

Quick Ratio (TTM)

EDIT3.13x

EIKN9.61x

Debt/Equity (TTM)

EDIT0.53x

EIKN0.00x

Debt/Assets (TTM)

EDIT0.0%

EIKN0.0%

Interest Coverage (TTM)

EDITN/A

EIKNN/A

Net Debt/EBITDA (TTM)

EDIT0.00x

EIKN0.00x

Beta

EDIT2.12

EIKN1.90

52W Performance

EDIT-30.1%

EIKN-50.2%

YTD Performance

EDIT41.5%

EIKN-50.2%

% from 52W High

EDIT-33.0%

EIKN-57.1%

% from 52W Low

EDIT74.7%

EIKN6.5%

Asset Turnover (TTM)

EDIT0.24x

EIKN0.00x

FCF Yield (TTM)

EDIT-24.8%

EIKN-96.6%

Earnings Yield (TTM)

EDIT-15.2%

EIKN-124.9%

Dividend Yield (TTM)

EDITN/A

EIKNN/A

Rule of 40

EDIT-235.6

EIKN0.0

EV/GP/RG

EDITN/A

EIKNN/A

Ticker research

View EDIT research View EIKN research

Metric	EDIT Editas Medicine Inc	EIKN Eikon Therapeutics Inc
Market & Valuation
Market Cap	$487M	$404M
Enterprise Value	$361M	$262M
Price	$2.90	$7.47
P/E Ratio	N/A	N/A
P/S Ratio	10.35x	0.00x
EV/Sales	7.67x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.82x	0.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.99x	-0.67x
PEG Ratio	N/A	0.00x
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	27.22x	N/A
Revenue & Growth
Revenue (TTM)	$47M	$0
Revenue Growth (YoY)	20.8%	N/A
Forward Rev Growth	-18.4%	436.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-172.4%	0.0%
Net Margin (TTM)	-157.3%	0.0%
FCF Margin (TTM)	-256.5%	N/A
Net Income (TTM)	$-74M	$-505M
FCF (TTM)	$-121M	$-391M
EPS (TTM)	-$0.62	-$9.33
ROE (TTM)	-19663.0%	-11966.0%
ROA (TTM)	-3817.0%	-6914.0%
ROIC (TTM)	-7815.0%	-11966.0%
Financial Health
Cash	$182M	$143M
Debt	$56M	$0
Net Cash/Debt	$126M	$143M
Current Ratio (TTM)	3.19x	9.89x
Quick Ratio (TTM)	3.13x	9.61x
Debt/Equity (TTM)	0.53x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.12	1.90
52W Performance	-30.1%	-50.2%
YTD Performance	41.5%	-50.2%
% from 52W High	-33.0%	-57.1%
% from 52W Low	74.7%	6.5%
Efficiency & Yields
Asset Turnover (TTM)	0.24x	0.00x
FCF Yield (TTM)	-24.8%	-96.6%
Earnings Yield (TTM)	-15.2%	-124.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-235.6	0.0
EV/GP/RG	N/A	N/A
Ticker research	View EDIT research	View EIKN research

Valuation

P/S Ratio

EIKN

0.00x

EDIT

10.35x

EV/FCF

EDIT

-2.99x

EIKN

-0.67x

Growth & revenue

Revenue Growth TTM

EDIT

20.8%

Forward Revenue Growth

EIKN

436.8%

EDIT

-18.4%

Profitability & performance

Gross Margin

EDIT

0.0%

EIKN

0.0%

ROE

EIKN

-11966.0%

EDIT

-19663.0%

FCF Yield %

EDIT

-24.8%

EIKN

-96.6%

52-Week Performance

EDIT

-30.1%

EIKN

-50.2%

Detailed metrics comparison

EDIT

Editas Medicine Inc

EIKN

Eikon Therapeutics Inc

Market Cap

EDIT$487M

EIKN$404M

Enterprise Value

EDIT$361M

EIKN$262M

Price

EDIT$2.90

EIKN$7.47

P/E Ratio

EDITN/A

EIKNN/A

P/S Ratio

EDIT10.35x

EIKN0.00x

EV/Sales

EDIT7.67x

EIKN0.00x

EV/EBITDA

EDIT0.00x

EIKN0.00x

P/B Ratio

EDIT3.82x

EIKN0.85x

P/FCF Ratio

EDITN/A

EIKNN/A

EV/FCF

EDIT-2.99x

EIKN-0.67x

PEG Ratio

EDITN/A

EIKN0.00x

Forward P/E (NTM)

EDITN/A

EIKNN/A

Forward P/S (NTM)

EDIT27.22x

EIKNN/A

Revenue (TTM)

EDIT$47M

EIKN$0

Revenue Growth (YoY)

EDIT20.8%

EIKNN/A

Forward Rev Growth

EDIT-18.4%

EIKN436.8%

Gross Margin (TTM)

EDIT0.0%

EIKN0.0%

Operating Margin (TTM)

EDIT0.0%

EIKN0.0%

EBITDA Margin (TTM)

EDIT-172.4%

EIKN0.0%

Net Margin (TTM)

EDIT-157.3%

EIKN0.0%

FCF Margin (TTM)

EDIT-256.5%

EIKNN/A

Net Income (TTM)

EDIT$-74M

EIKN$-505M

FCF (TTM)

EDIT$-121M

EIKN$-391M

EPS (TTM)

EDIT-$0.62

EIKN-$9.33

ROE (TTM)

EDIT-19663.0%

EIKN-11966.0%

ROA (TTM)

EDIT-3817.0%

EIKN-6914.0%

ROIC (TTM)

EDIT-7815.0%

EIKN-11966.0%

Cash

EDIT$182M

EIKN$143M

Debt

EDIT$56M

EIKN$0

Net Cash/Debt

EDIT$126M

EIKN$143M

Current Ratio (TTM)

EDIT3.19x

EIKN9.89x

Quick Ratio (TTM)

EDIT3.13x

EIKN9.61x

Debt/Equity (TTM)

EDIT0.53x

EIKN0.00x

Debt/Assets (TTM)

EDIT0.0%

EIKN0.0%

Interest Coverage (TTM)

EDITN/A

EIKNN/A

Net Debt/EBITDA (TTM)

EDIT0.00x

EIKN0.00x

Beta

EDIT2.12

EIKN1.90

52W Performance

EDIT-30.1%

EIKN-50.2%

YTD Performance

EDIT41.5%

EIKN-50.2%

% from 52W High

EDIT-33.0%

EIKN-57.1%

% from 52W Low

EDIT74.7%

EIKN6.5%

Asset Turnover (TTM)

EDIT0.24x

EIKN0.00x

FCF Yield (TTM)

EDIT-24.8%

EIKN-96.6%

Earnings Yield (TTM)

EDIT-15.2%

EIKN-124.9%

Dividend Yield (TTM)

EDITN/A

EIKNN/A

Rule of 40

EDIT-235.6

EIKN0.0

EV/GP/RG

EDITN/A

EIKNN/A

Ticker research

View EDIT research View EIKN research

Metric	EDIT Editas Medicine Inc	EIKN Eikon Therapeutics Inc
Market & Valuation
Market Cap	$487M	$404M
Enterprise Value	$361M	$262M
Price	$2.90	$7.47
P/E Ratio	N/A	N/A
P/S Ratio	10.35x	0.00x
EV/Sales	7.67x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.82x	0.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.99x	-0.67x
PEG Ratio	N/A	0.00x
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	27.22x	N/A
Revenue & Growth
Revenue (TTM)	$47M	$0
Revenue Growth (YoY)	20.8%	N/A
Forward Rev Growth	-18.4%	436.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-172.4%	0.0%
Net Margin (TTM)	-157.3%	0.0%
FCF Margin (TTM)	-256.5%	N/A
Net Income (TTM)	$-74M	$-505M
FCF (TTM)	$-121M	$-391M
EPS (TTM)	-$0.62	-$9.33
ROE (TTM)	-19663.0%	-11966.0%
ROA (TTM)	-3817.0%	-6914.0%
ROIC (TTM)	-7815.0%	-11966.0%
Financial Health
Cash	$182M	$143M
Debt	$56M	$0
Net Cash/Debt	$126M	$143M
Current Ratio (TTM)	3.19x	9.89x
Quick Ratio (TTM)	3.13x	9.61x
Debt/Equity (TTM)	0.53x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.12	1.90
52W Performance	-30.1%	-50.2%
YTD Performance	41.5%	-50.2%
% from 52W High	-33.0%	-57.1%
% from 52W Low	74.7%	6.5%
Efficiency & Yields
Asset Turnover (TTM)	0.24x	0.00x
FCF Yield (TTM)	-24.8%	-96.6%
Earnings Yield (TTM)	-15.2%	-124.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-235.6	0.0
EV/GP/RG	N/A	N/A
Ticker research	View EDIT research	View EIKN research